EarningsQ4 2025 Earnings Report

Astellas Pharma (4503N) Q4 2025 Earnings Report

1 Followers

MX:4503N Q4 2025 EPS Results

Actual EPS$2.90

Consensus EPS$3.65

Beat/MissMissed by -$0.75

One Year Ago EPS$4.99

Actual Revenue$64.13B

Expected Revenue$61.06B

Beat/MissBeat by +$3.07B

YoY Revenue Growth+17.12%

QuarterQ4 2025

Date04/27/2026

TimeBefore Open

Conference CallMonday, April 27, 2026

MX:4503N Upcoming Earnings

Astellas Pharma's next earnings date is estimated for November 4, 2026, based on past reporting schedules.

MX:4503N Q4 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 04, 2026	2026 (Q2)	7.75 / -	5.272	―
Aug 05, 2026	2026 (Q1)	6.45 / 9.44	4.557	107.09% (+4.88)
Apr 27, 2026	2025 (Q4)	3.65 / 2.90	4.988	-41.95% (-2.09)
Feb 04, 2026	2025 (Q3)	5.48 / 6.68	-6.503	202.73% (+13.18)
Oct 30, 2025	2025 (Q2)	3.55 / 5.27	2.392	120.44% (+2.88)
Jul 30, 2025	2025 (Q1)	2.37 / 4.56	2.504	82.00% (+2.05)
Apr 25, 2025	2024 (Q4)	2.54 / 4.99	-2.212	325.50% (+7.20)
Feb 04, 2025	2024 (Q3)	2.92 / -6.50	1.24	-624.52% (-7.74)
Oct 30, 2024	2024 (Q2)	2.15 / 2.39	-0.095	2607.50% (+2.49)
Aug 01, 2024	2024 (Q1)	1.14 / 2.50	2.201	13.76% (+0.30)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed